These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29016875)

  • 1. Occupancy of Norepinephrine Transporter by Duloxetine in Human Brains Measured by Positron Emission Tomography with (S,S)-[18F]FMeNER-D2.
    Moriguchi S; Takano H; Kimura Y; Nagashima T; Takahata K; Kubota M; Kitamura S; Ishii T; Ichise M; Zhang MR; Shimada H; Mimura M; Meyer JH; Higuchi M; Suhara T
    Int J Neuropsychopharmacol; 2017 Dec; 20(12):957-962. PubMed ID: 29016875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norepinephrine transporter occupancy by antidepressant in human brain using positron emission tomography with (S,S)-[18F]FMeNER-D2.
    Sekine M; Arakawa R; Ito H; Okumura M; Sasaki T; Takahashi H; Takano H; Okubo Y; Halldin C; Suhara T
    Psychopharmacology (Berl); 2010 Jun; 210(3):331-6. PubMed ID: 20309528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2.
    Seneca N; Gulyás B; Varrone A; Schou M; Airaksinen A; Tauscher J; Vandenhende F; Kielbasa W; Farde L; Innis RB; Halldin C
    Psychopharmacology (Berl); 2006 Sep; 188(1):119-27. PubMed ID: 16896954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2).
    Nogami T; Takano H; Arakawa R; Ichimiya T; Fujiwara H; Kimura Y; Kodaka F; Sasaki T; Takahata K; Suzuki M; Nagashima T; Mori T; Shimada H; Fukuda H; Sekine M; Tateno A; Takahashi H; Ito H; Okubo Y; Suhara T
    Int J Neuropsychopharmacol; 2013 Jun; 16(5):937-43. PubMed ID: 23067569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of norepinephrine transporter in the human brain using PET with (S,S)-18F-FMeNER-D2.
    Arakawa R; Okumura M; Ito H; Seki C; Takahashi H; Takano H; Nakao R; Suzuki K; Okubo Y; Halldin C; Suhara T
    J Nucl Med; 2008 Aug; 49(8):1270-6. PubMed ID: 18632811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venlafaxine ER Blocks the Norepinephrine Transporter in the Brain of Patients with Major Depressive Disorder: a PET Study Using [18F]FMeNER-D2.
    Arakawa R; Stenkrona P; Takano A; Svensson J; Andersson M; Nag S; Asami Y; Hirano Y; Halldin C; Lundberg J
    Int J Neuropsychopharmacol; 2019 Apr; 22(4):278-285. PubMed ID: 30649319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET Quantification of the Norepinephrine Transporter in Human Brain with (
    Moriguchi S; Kimura Y; Ichise M; Arakawa R; Takano H; Seki C; Ikoma Y; Takahata K; Nagashima T; Yamada M; Mimura M; Suhara T
    J Nucl Med; 2017 Jul; 58(7):1140-1145. PubMed ID: 27980046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin and Norepinephrine Transporter Occupancy of Tramadol in Nonhuman Primate Using Positron Emission Tomography.
    Arakawa R; Takano A; Halldin C
    Int J Neuropsychopharmacol; 2019 Jan; 22(1):53-56. PubMed ID: 30346535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[¹⁸F]FMeNER-D₂.
    Takano H; Arakawa R; Nogami T; Suzuki M; Nagashima T; Fujiwara H; Kimura Y; Kodaka F; Takahata K; Shimada H; Murakami Y; Tateno A; Yamada M; Ito H; Kawamura K; Zhang MR; Takahashi H; Kato M; Okubo Y; Suhara T
    Int J Neuropsychopharmacol; 2014 Apr; 17(4):553-60. PubMed ID: 24345533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging the norepinephrine transporter with positron emission tomography: initial human studies with (S,S)-[18F]FMeNER-D2.
    Takano A; Gulyás B; Varrone A; Karlsson P; Schou M; Airaksinen AJ; Vandenhende F; Tauscher J; Halldin C
    Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):153-7. PubMed ID: 17909794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain.
    Schou M; Halldin C; Sóvágó J; Pike VW; Hall H; Gulyás B; Mozley PD; Dobson D; Shchukin E; Innis RB; Farde L
    Synapse; 2004 Aug; 53(2):57-67. PubMed ID: 15170818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norepinephrine transporter occupancy in the human brain after oral administration of quetiapine XR.
    Nyberg S; Jucaite A; Takano A; Kågedal M; Cselényi Z; Halldin C; Farde L
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2235-44. PubMed ID: 23809226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of human serotonin and norepinephrine transporter occupancy of duloxetine by pharmacokinetic/pharmacodynamic modeling in the rat.
    Bourdet DL; Tsuruda PR; Obedencio GP; Smith JA
    J Pharmacol Exp Ther; 2012 Apr; 341(1):137-45. PubMed ID: 22235148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saturated norepinephrine transporter occupancy by atomoxetine relevant to clinical doses: a rhesus monkey study with (S,S)-[(18)F]FMeNER-D (2).
    Takano A; Gulyás B; Varrone A; Maguire RP; Halldin C
    Eur J Nucl Med Mol Imaging; 2009 Aug; 36(8):1308-14. PubMed ID: 19300997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [18F]FMeNER-D2: reliable fully-automated synthesis for visualization of the norepinephrine transporter.
    Rami-Mark C; Zhang MR; Mitterhauser M; Lanzenberger R; Hacker M; Wadsak W
    Nucl Med Biol; 2013 Nov; 40(8):1049-54. PubMed ID: 24100201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between serotonin transporter occupancies and analgesic effects of AS1069562, the (+)-isomer of indeloxazine, and duloxetine in reserpine-induced myalgia rats.
    Murai N; Fushiki H; Honda S; Murakami Y; Iwashita A; Irie M; Tamura S; Nagakura Y; Aoki T
    Neuroscience; 2015 Mar; 289():262-9. PubMed ID: 25595980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution and radiation dosimetry of the norepinephrine transporter radioligand (S,S)-[18F]FMeNER-D2: a human whole-body PET study.
    Takano A; Halldin C; Varrone A; Karlsson P; Sjöholm N; Stubbs JB; Schou M; Airaksinen AJ; Tauscher J; Gulyás B
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):630-6. PubMed ID: 18000665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of the norepinephrine transporter in the human brain using PET with (S,S)-[18F]FMeNER-D2.
    Takano A; Varrone A; Gulyás B; Karlsson P; Tauscher J; Halldin C
    Neuroimage; 2008 Aug; 42(2):474-82. PubMed ID: 18617423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dose-finding study of duloxetine based on serotonin transporter occupancy.
    Takano A; Suzuki K; Kosaka J; Ota M; Nozaki S; Ikoma Y; Tanada S; Suhara T
    Psychopharmacology (Berl); 2006 Apr; 185(3):395-9. PubMed ID: 16506079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of positron emission tomography radiotracers for imaging the norepinephrine transporter: (S,S) and (R,R) enantiomers of reboxetine analogs ([11C]methylreboxetine, 3-Cl-[11C]methylreboxetine and [18F]fluororeboxetine), (R)-[11C]nisoxetine, [11C]oxaprotiline and [11C]lortalamine.
    Ding YS; Lin KS; Logan J; Benveniste H; Carter P
    J Neurochem; 2005 Jul; 94(2):337-51. PubMed ID: 15998285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.